Pricing Log in Create free account

iBio, Inc. (IBIO) vs Serina Therapeutics, Inc. (SER)

iBio, Inc. and Serina Therapeutics, Inc. are both Biotechnology companies. iBio, Inc. and Serina Therapeutics, Inc. are of similar size ($44.4M and $41.9M). iBio, Inc. grew revenue faster over the last twelve months: −66.6% against −94.2%. Across the 13 metrics below, iBio, Inc. leads on 11 and Serina Therapeutics, Inc. on 2.

Valuation

Metric IBIO SER Biotechnology median
P/E n/m n/m 10.60
P/S 115.62 126.73 9.40
P/B 0.91 1.22 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.25 n/m 0.66
EV/Sales (12.78) 32.54 9.02
Earnings yield (45.33%) (135.00%) (32.88%)
Free cash flow yield (31.04%) (92.42%) (23.13%)

Profitability

Metric IBIO SER Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.70%) (306.22%) (51.96%)
Return on assets (54.04%) (136.00%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IBIO SER Biotechnology median
Revenue growth (TTM) (66.55%) (94.21%) 6.76%
EPS growth (last fiscal year) 81.71% (26.49%) 29.88%
Revenue growth, 5-year CAGR (42.83%) (18.48%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IBIO SER Biotechnology median
Debt to equity 0.00 0.16 0.00
Current ratio 7.85 6.65 4.97
Net debt to EBITDA 2.57 0.00 1.01

Dividend

Metric IBIO SER Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IBIO SER Biotechnology median
Market cap 44.43m 41.91m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack